High Tech Pharm Co., Ltd. (KOSDAQ:106190)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,580
-90 (-0.71%)
At close: Aug 7, 2025, 3:30 PM KST
-0.71%
Market Cap133.77B
Revenue (ttm)73.58B
Net Income (ttm)12.63B
Shares Out10.63M
EPS (ttm)1,187.54
PE Ratio10.59
Forward PEn/a
Dividend100.00 (0.79%)
Ex-Dividend DateDec 27, 2024
Volume5,899
Average Volume18,163
Open12,720
Previous Close12,670
Day's Range12,500 - 12,720
52-Week Range11,300 - 17,980
Beta0.80
RSI44.09
Earnings DateAug 13, 2025

About Endeavor Group Holdings

High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1998
Employees 65
Stock Exchange KOSDAQ
Ticker Symbol 106190
Full Company Profile

Financial Performance

In 2024, High Tech Pharm's revenue was 77.51 billion, an increase of 0.97% compared to the previous year's 76.77 billion. Earnings were 13.71 billion, an increase of 69.75%.

Financial Statements

News

There is no news available yet.